Clinical Trial Update: Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update indicates completion of ferritin screening and iron treatment to prevent maternal anemia and fetal growth restriction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction
• Iron Deficiency Without Anemia

Drugs mentioned

• Ferrous sulfate (ferrous sulfate)

Snippet

Sponsor: Services Institute of Medical Sciences, Pakistan | Conditions: Iron Deficiency (Without Anemia), Pregnancy Related | Phase 4 | Status: COMPLETED